Showing results (71-80 of 127) with videos related to
Sort By:
Pageof 13
Arthritis and Rheumatism|October 18, 2002
Familiality and co-occurrence of clinical features of systemic lupus erythematosusBetty P Tsao, Jennifer M Grossman, Gabriela Riemekasten, et al.Arthritis and Rheumatism|December 1, 2011
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosusRichard Furie, Michelle Petri, Omid Zamani, et al.Arthritis Care & Research|May 31, 2022
Evaluation of the EULAR/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus in a Population-Based RegistryAllison Guttmann, Brendan Denvir, Martin Aringer, et al.Arthritis Research & Therapy|August 21, 2015
Treatment of systemic lupus erythematosus patients with the BAFF antagonist "peptibody" blisibimod (AMG 623/A-623): results from randomized, double-blind phase 1a and phase 1b trialsWilliam Stohl, Joan T Merrill, R John Looney, et al.Arthritis and Rheumatism|June 1, 1982
A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosisE M Ginzler, H S Diamond, M Weiner, et al.Arthritis & Rheumatology (Hoboken, N.J.)|July 19, 2023
Safety and Efficacy of Long-Term Voclosporin Treatment for Lupus Nephritis in the Phase 3 AURORA 2 Clinical TrialAmit Saxena, Ellen M Ginzler, Keisha Gibson, et al.Arthritis and Rheumatism|June 1, 1982
A multicenter study of outcome in systemic lupus erythematosus. II. Causes of deathS Rosner, E M Ginzler, H S Diamond, et al.Frontiers in Epidemiology|March 22, 2024
Prevalence of concomitant rheumatologic diseases and autoantibody specificities among racial and ethnic groups in SLE patientsBrendan Denvir, Philip M Carlucci, Kelly Corbitt, et al.Arthritis Research & Therapy|September 13, 2024
Prevalence of cardiovascular events in a population-based registry of patients with systemic lupus erythematosusDaniel P Joyce, Jeffrey S Berger, Allison Guttmann, et al.Journal of the Neurological Sciences|October 28, 2022
Predictors of overlapping autoimmune disease in Neuromyelitis Optica Spectrum disorder (NMOSD): A retrospective analysis in two inner-city hospitalsMilena Rodriguez Alvarez, Aveena Gurung, Vinodkumar Velayndhan, et al.Pageof 13